Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia by Wang L, Giannoudis A, Lane S, Williamson P, Pirmohamed M, Clark R E in Clinical pharmacology and therapeutics (2008).

[PMID: 17568400] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.